Prognostic risk factors of buccal squamous cell carcinoma: A case–control study

Abstract

AbstractObjectivesTo describe the clinicopathologic presentation of buccal squamous cell carcinoma and identify risks factors for recurrence and overall survival.MethodsThis is a retrospective case–control study of patients with oral cavity squamous cell carcinoma (OCSCC) treated at a single tertiary care center between 2010 and 2022. All patients with buccal subsite OCSCC treated during this time frame were included and paired with a randomly selected age and gender matched patient with non‐buccal OCSCC. Relevant data was collected via chart review.ResultsSeventy‐seven patients with buccal SCC were matched with 77 non‐buccal OCSCC controls. The median follow‐up time was 27 months (IQR 14–61). Median age was 67 years (IQR 57–75) and 53% of the cohort was female. Twenty (26%) buccal SCC patients experienced a recurrence versus 19 (25%) in the controls. Age ≥65‐years‐old increased odds of all‐cause mortality in the buccal SCC group, but not in the control group. Perineural invasion and positive margins increased odds of recurrence in the buccal group only. Overall survival and progression‐free survival did not differ between the groups, despite a greater number of T2 buccal tumors and T1 non‐buccal tumors.ConclusionsBuccal SCC presents at a higher T stage than other oral cavity SCC subsite and may exhibit variance in the pathologic risk factors that predict poor outcomes versus non‐buccal OCSCC. Despite these relatively minor differences, however, oncologic outcomes between these groups were similar.